Literature DB >> 30245090

Surgical management for middle or lower thoracic spinal tuberculosis (T5-T12) in elderly patients: Posterior versus anterior approach.

Zhongyang Li1, Fei Lei1, Peng Xiu1, Xi Yang1, Lei Wang1, Ganjun Feng1, Limin Liu1, Yueming Song1, Chunguang Zhou2.   

Abstract

BACKGROUND: Spinal tuberculosis accounts for more than 50% of bone tuberculosis cases. This study compared clinical, radiological and functional outcomes between anterior and posterior approaches for treatment of middle or lower thoracic spinal tuberculosis in elderly patients.
METHODS: We retrospectively examined middle or lower thoracic spinal tuberculosis (T5-T12) in patients over 65 years. All procedures included debridement, decompression, autologous bone graft and fixation. Surgical procedure, surgical duration, estimated blood loss during surgery and laboratory results were recorded. Pleural effusion volume, thoracic cavity volume, Oswestry Disability Index score, neurological status, radiological parameters and complication rate were evaluated.
RESULTS: No significant difference was found in surgical duration, blood loss, kyphosis angle correction, loss of correction, thoracic cavity volume, or complication rate between the two groups (P > 0.05). Average postoperative pleural effusion volumes were 605.9 ± 209.5 mL (377-1074 mL) and 262.9 ± 228.1 mL (0-702.4 mL) in the anterior and posterior groups, respectively (P = 0.004). Average hospitalization durations were 26.4 ± 10.5 days (17-53 days) and 19.2 ± 5.0 days (14-30 days) (P = 0.04). Average postoperative serum albumin levels were 24.19 ± 3.84 g/L (19-29.5 g/L) and 28.24 ± 2.52 g/L (24.4-31.6 g/L) (P = 0.01). No relapse or reinfection was observed in either group at the final follow-up. Surgical revision was not required in either group.
CONCLUSIONS: Both anterior and posterior surgeries can be used to treat middle or lower thoracic spinal (T5-T12) tuberculosis in elderly patients. In general, the posterior approach might be superior, especially for patients with poor general health.
Copyright © 2018 The Japanese Orthopaedic Association. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30245090     DOI: 10.1016/j.jos.2018.08.012

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  5 in total

1.  Comparison of anterior or posterior approach in surgical treatment of thoracic and lumbar tuberculosis: a retrospective case-control study.

Authors:  Jincheng Qiu; Yan Peng; Xianjian Qiu; Wenjie Gao; Tongzhou Liang; Yuanxin Zhu; Taiqiu Chen; Wenjun Hu; Bo Gao; Zhihuai Deng; Anjing Liang; Dongsheng Huang
Journal:  BMC Surg       Date:  2022-05-10       Impact factor: 2.030

2.  Comparison of Clinical Data Between Patients With Complications and Without Complications After Spinal Tuberculosis Surgery: A Propensity Score Matching Analysis.

Authors:  Liyi Chen; Chong Liu; Zhen Ye; Wuhua Chen; Xuhua Sun; Jiarui Chen; Hao Li; Tuo Liang; Shengsheng Huang; Jie Jiang; Tianyou Chen; Hao Guo; Yuanlin Yao; Shian Liao; Chaojie Yu; Shaofeng Wu; Binguang Fan; Xinli Zhan
Journal:  Front Surg       Date:  2022-03-29

3.  Efficacy analysis of one-stage posterior-only surgical treatment for thoracic spinal tuberculosis in the T4-6 segments with minimum 5-year follow-up.

Authors:  Yi Zhan; Xin Kang; Wenjie Gao; Xinliang Zhang; Lingbo Kong; Dingjun Hao; Biao Wang
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

4.  Posterior-only debridement, bone fusion, single-segment versus short-segment instrumentation for mono-segmental lumbar or lumbosacral pyogenic vertebral osteomyelitis: minimum five year follow-up outcomes.

Authors:  Hong-Qi Zhang; Yu-Xiang Wang; Chao-Feng Guo; Ming-Xing Tang; Shao-Hua Liu; Ang Deng; Qile Gao
Journal:  J Orthop Surg Res       Date:  2022-08-12       Impact factor: 2.677

5.  Research of a Safe and Simplified Intertransverse Process Approach for the Lower Thoracic Interbody Surgery.

Authors:  Nian-Hu Li; Rui-Qi Zou; Xue-Gang Zhao; Peng Kong; Chen Yue; Meng-Long Jia; Ping Jiang; Yu-Tong Li; Gang Li; Zhan-Wang Xu
Journal:  Orthop Surg       Date:  2022-07-12       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.